When we launched this petition, the FDA had just issued warning letters to NDT manufacturers and set an August 2026 deadline that no one was on track to meet. Patients were scared. Access felt uncertain.

Today we have real news to share: the FDA has committed to not taking enforcement action against NDT medications while manufacturers work toward formal approval.

That means Armour Thyroid, NP Thyroid, and other desiccated thyroid medications are not being pulled from the market.

Your signature — along with 9,534 others — was part of the pressure that made this happen. The thyroid community showed up, and decision makers noticed.

What this means for you right now:

Your NDT prescription is not at risk
Manufacturers have time to pursue formal FDA approval without disrupting patient care
The conversation about NDT legitimacy is shifting
This isn't the end of the fight. Manufacturers still need to pursue approval, and we'll continue advocating for every patient's right to the treatment that works for them.

Thank you for signing, sharing, and standing up for thyroid patients everywhere.

The Paloma Health Team
palomahealth.com